Combination of Amphotericin B and 5-Fluorocytosine

  • Annemarie Polak
  • H. J. Scholer
Part of the Chemotherapy book series (CT, volume 6)

Summary

Moderate synergism of fungistasis was demonstrated in all normally sensitive Cryptococcus neoformans and in the partially 5-fluorocytosine (5-FC)-resistant Candida albicans strains. Synergism of the fungicidal effect was found throughout. It was more pronounced in Sabouraud broth than in an antagonist-free medium. In all strains the appearance of 5-FC-resistant mutants was significantly reduced by subinhibitory concentrations of amphotericin B (amph. B).

Survival rate of mice treated with a combination of the two drugs was increased in comparison to that of animals treated with each drug alone, viable fungus cells in the organs being reduced in number. Mycological cure was only achieved by combined therapy.

Attempts were also made to explain the mechanism of synergism. Addition of amph. B was shown to increase incorporation of fluori-nated pyrimidine into RNA of the fungi. Decreased protein synthesis as produced by 5-FC alone was found more pronounced when amph. B was added in concentrations ineffective by themselves.

Keywords

Permeability Agar Fluori Assure Beach 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Beggs, W.H., Sarosi, G.A. and Andrews, F.A. (1974), Res. Comm. chenu Path. Pharm. 8, 559.Google Scholar
  2. Block, E.R. and Bennett, J.E. (1973), Proc. exp. Biol. 142, 476.Google Scholar
  3. Elion, C.B., Singer, S. and Hichtings, G.H. (1954), J. biol. Chem. 208, 477.PubMedGoogle Scholar
  4. Fields, B.T., Meredith, W.R., Galbraith, J.E. and Hardin, H.F. (1974), Clin. Res. 22, 32A.Google Scholar
  5. Garriques, I.L., Sande, M.A., Utz, J.P., Mandell, G.L., Warner, J. F., McGehee, R.F. and Shadomy, S. Abstract presented at the 13th Int. Conference on Antimicrobial Agents and Chemotherapy, Washington, September, 1973.Google Scholar
  6. Gosh, A.J. and Gosh, J. (1963), Ann. Biochem. 13, 611.Google Scholar
  7. Halkin, H., Ravid, M., Zulman, J. and Reichert, N. (1974), Israel J. med. Sci. 10, 1148.PubMedGoogle Scholar
  8. Hamilton, J.D. and Elliot, D.M. (1975), J. infect. Dis. 131, 129.PubMedCrossRefGoogle Scholar
  9. Kitahara, M., Medoff, G. and Kobayashi, G.S. Abstract presented at the 14th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, September, 1974.Google Scholar
  10. Medoff, G., Kobayashi, G.S., Kwan, C.N., Schlesinger, D. and Venkov, P. (1972), Proc. nat. Acad. Sci. USA 69, 196.PubMedCrossRefGoogle Scholar
  11. Medoff, G., Comfort, M. and Kobayahi, G.S. (1971), Proc. Soc. exp. Biol. Med. 138, 571.PubMedGoogle Scholar
  12. Montgomerie, J.Z., Edwards, J.E. and Guze, L.B. (1974), Clin. Res. 22, 450A.Google Scholar
  13. Polak, A. (1974), Bull. Soc. fr. Mycol. Méd. 3, 175.Google Scholar
  14. Shadomy, S. and Davis, B. Abstract presented at the Annual Meeting of the American Society of Microbiology, Miami Beach, May, 1973.Google Scholar
  15. Shaw, D.B., Rabinovich, S. and Donta, S.T. Abstract presented at the Annual Meeting of the American Society of Microbiology, Ann Arbor, 1972.Google Scholar
  16. Rabinovich, S., Shaw, B.D., Bryant, T. and Donta, S.T. (1974), J. infect. Dis. 130, 28.PubMedCrossRefGoogle Scholar
  17. Titsworth, E. and Grunberg, E. (1973), Antimicrob. Ag. Chemother. 4, 306.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1976

Authors and Affiliations

  • Annemarie Polak
    • 1
  • H. J. Scholer
    • 1
  1. 1.Department of Experimental MedicineF. Hoffmann-La Roche & Co. Ltd.BasleSwitzerland

Personalised recommendations